Human Immune System Mice for the Study of Human Immunodeficiency Virus-Type 1 Infection of the Central Nervous System
- PMID: 29670623
- PMCID: PMC5893637
- DOI: 10.3389/fimmu.2018.00649
Human Immune System Mice for the Study of Human Immunodeficiency Virus-Type 1 Infection of the Central Nervous System
Abstract
Immunodeficient mice transplanted with human cell populations or tissues, also known as human immune system (HIS) mice, have emerged as an important and versatile tool for the in vivo study of human immunodeficiency virus-type 1 (HIV-1) pathogenesis, treatment, and persistence in various biological compartments. Recent work in HIS mice has demonstrated their ability to recapitulate critical aspects of human immune responses to HIV-1 infection, and such studies have informed our knowledge of HIV-1 persistence and latency in the context of combination antiretroviral therapy. The central nervous system (CNS) is a unique, immunologically privileged compartment susceptible to HIV-1 infection, replication, and immune-mediated damage. The unique, neural, and glia-rich cellular composition of this compartment, as well as the important role of infiltrating cells of the myeloid lineage in HIV-1 seeding and replication makes its study of paramount importance, particularly in the context of HIV-1 cure research. Current work on the replication and persistence of HIV-1 in the CNS, as well as cells of the myeloid lineage thought to be important in HIV-1 infection of this compartment, has been aided by the expanded use of these HIS mouse models. In this review, we describe the major HIS mouse models currently in use for the study of HIV-1 neuropathogenesis, recent insights from the field, limitations of the available models, and promising advances in HIS mouse model development.
Keywords: HIV-associated neurocognitive disorders; central nervous system; human immune system mice; human immunodeficiency virus; myeloid cells.
Similar articles
-
HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.J Virol. 2018 Mar 14;92(7):e02118-17. doi: 10.1128/JVI.02118-17. Print 2018 Apr 1. J Virol. 2018. PMID: 29343582 Free PMC article.
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
Humanized Mouse Models for Human Immunodeficiency Virus Infection.Annu Rev Virol. 2017 Sep 29;4(1):393-412. doi: 10.1146/annurev-virology-101416-041703. Epub 2017 Jul 26. Annu Rev Virol. 2017. PMID: 28746819 Free PMC article. Review.
-
Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.AIDS Res Hum Retroviruses. 2018 Jan;34(1):3-8. doi: 10.1089/AID.2017.0072. Epub 2017 Aug 7. AIDS Res Hum Retroviruses. 2018. PMID: 28691499 Free PMC article. Review.
-
HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy.Curr Opin Virol. 2019 Oct;38:54-62. doi: 10.1016/j.coviro.2019.06.004. Epub 2019 Aug 4. Curr Opin Virol. 2019. PMID: 31390580 Review.
Cited by
-
HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.Neurosci Lett. 2021 May 29;754:135863. doi: 10.1016/j.neulet.2021.135863. Epub 2021 Mar 29. Neurosci Lett. 2021. PMID: 33794296 Free PMC article. Review.
References
-
- UNAIDS. UNAIDS Fact Sheet November 2016. Global HIV Statistics. Geneva: UNAIDS; (2016).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical